Cite
HARVARD Citation
Mahdi, A. et al. (2018). Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes. British journal of haematology. pp. 603-604. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mahdi, A. et al. (2018). Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes. British journal of haematology. pp. 603-604. [Online].